TLR2 and neoplasm: To enhance the activity of synthetic carbohydrate antigens in boosting the anti-tumor responses, we selected Pam3CSK4, which is an effective TLR2 agonist that activates the innate immune system, as the pattern molecule to add to the carbohydrate antigens.